Bulletin
Investor Alert

New York Markets After Hours

Company Close Updates Archives | Email alerts

May 21, 2021, 5:01 p.m. EDT

Inovio Pharmaceuticals Inc. stock falls Friday, underperforms market

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Inovio Pharmaceuticals Inc. INO slipped 0.98% to $7.06 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA rising 0.36% to 34,207.84 and the NASDAQ Composite Index COMP falling 0.48% to 13,470.99. Inovio Pharmaceuticals Inc. closed $26.73 short of its 52-week high ($33.79), which the company achieved on June 26th.

The stock underperformed when compared to some of its competitors Friday, as AbbVie Inc. ABBV fell 0.85% to $116.12, Amgen Inc. AMGN fell 0.37% to $251.01, and AstraZeneca PLC ADR AZN fell 0.07% to $57.40. Trading volume (3.4 M) remained 5.7 million below its 50-day average volume of 9.1 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Get news alerts on Inovio Pharmaceuticals Inc. — or create your own.
This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.